PRASCO 326 (Phenylephrine and Guaifenesin SR 25 mg / 900 mg)
Pill with imprint PRASCO 326 is White, Capsule-shape and has been identified as Phenylephrine and Guaifenesin SR 25 mg / 900 mg. It is supplied by Prasco Laboratories.
Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 25 mg / 900 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PRASCO 326
Phenylephrine and Guaifenesin SR
- Imprint
- PRASCO 326
- Strength
- 25 mg / 900 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Prasco Laboratories
- National Drug Code (NDC)
More about guaifenesin / phenylephrine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 12 Reviews
- Drug class: upper respiratory combinations
- FDA Alerts (1)
Consumer resources
- Patient Information
- Guaifenesin and Phenylephrine Drops
- Guaifenesin and Phenylephrine Liquid
- Guaifenesin and Phenylephrine Tablets
- Other brands
- Deconex, Deconex IR, Aldex G, Rescon-GG, ... +14 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.